European Heart Journal Cardiovascular Pharmacotherapy

Switching to Angiotensin Receptor-Neprilysin Inhibitor and Reduced Risk of New-Onset Atrial Fibrillation in Heart Failure with Reduced Ejection Fraction: A Nationwide Propensity Score-Matched Study

Study in peopleInterventions

The paper

Korea University Anam Hospital; Yonsei University

European Heart Journal Cardiovascular Pharmacotherapy, 15 Sep 2026

doi.org/10.1093/ehjcvp/pvag074PubMed 42740677